Chinese pork supply chain hit by growth drug scandal

A Canadian shipment of port to China that has tested positive for a banned growth drug could hit trade with the world’s biggest importer.

China said it viewed the tainted shipment as a “systemic failure” of Canada’s programme that certifies pork sent to China is ractompamine-free and the situation “could affect future pork exports,” according to an email from the Canadian Food Inspection Agency (CFIA) circulated to the industry.

To read the rest of this article you need to sign in:

Membership ID / Email Address

Password

Don't have an account? Register here

JOIN CIPS

Not a CIPS member? Why not join CIPS to access a full range of benefits, including:

Access all areas of the CIPS Knowledge on-line library including tools and templates and Supply Management stories.
Enhance your network and get connected to a global community of 120,000 in 150 countries.
Stay in touch and up to date through member only events and branch meetings.
Annual subscription to Supply Management magazine.
10 per cent discount on all training courses, workshops, seminars and conferences.
Up to 15 per cent discount on books from the CIPS book store, including course books and a range of further reading text books.

And much more. Click here to join >

Chinese pork supply chain hit by growth drug scandal

SIGN UP

JOIN CIPS